Vestor Capital’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-10,000
Closed -$157K 232
2022
Q2
$157K Hold
10,000
0.02% 117
2022
Q1
$152K Hold
10,000
0.02% 127
2021
Q4
$154K Buy
10,000
+5,000
+100% +$65.8K 0.01% 130
2021
Q3
$44K Hold
5,000
﹤0.01% 225
2021
Q2
$51K Hold
5,000
0.01% 196
2021
Q1
$60K Hold
5,000
0.01% 178
2020
Q4
$45K Buy
+5,000
New +$38.7K 0.01% 191

Other funds holding NPTN

Vestor Capital's NPTN Position: Q3 2022 in Review

Vestor Capital sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 10,000 shares — an estimated $157K sold.

Vestor Capital first reported a position in NPTN in Q4 2020 and held it in 7 quarters. The position peaked at $157K in Q2 2022. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

  • Vestor Capital reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
  • Vestor Capital sold 10,000 NEOPHOTONICS CORP shares in Q3 2022, an estimated $157K.
  • Vestor Capital first reported a position in NEOPHOTONICS CORP in Q4 2020 and held it in 7 quarters.
  • Vestor Capital's NEOPHOTONICS CORP position peaked at $157K in Q2 2022.
  • 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on Vestor Capital's 13F filing for Q3 2022, filed 14 Nov 2022.